| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 2 |
| 1 | CAPECITABINE | 2 |
| 2 | DICLOFENAC | 2 |
| 3 | DICLOFENAC SODIUM | 2 |
| 4 | OXALIPLATIN | 2 |
| 5 | ACETAMINOPHEN | 1 |
| 6 | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | 1 |
| 7 | ADRENALINUM | 1 |
| 8 | CLONIDINE HYDROCHLORIDE | 1 |
| 9 | DICLOFENAC SODIUM 1% | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | IBALIZUMAB | 1 | 0.0019 |
| 1 | CLONIDINE HYDROCHLORIDE | 1 | 0.0002 |
| 2 | PEGVALIASE-PQPZ | 1 | 0.0001 |
| 3 | DICLOFENAC SODIUM 1% | 1 | 0.0000 |
| 4 | DICLOFENAC SODIUM TOPICAL GEL, 1% | 1 | 0.0000 |
| 5 | OXALIPLATIN | 2 | 0.0000 |
| 6 | CAPECITABINE | 2 | 0.0000 |
| 7 | FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE | 1 | 0.0000 |
| 8 | BEVACIZUMAB | 2 | 0.0000 |
| 9 | EPINEPHRINE | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD4-directed Blocking Antibody [EPC] | 1 | 0.0019 |
| 1 | Phenylalanine Metabolizing Enzyme [EPC] | 1 | 0.0001 |
| 2 | Catecholamine [EPC] | 1 | 0.0000 |
| 3 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 2 | 0.0000 |
| 4 | Aminosalicylate [EPC] | 1 | 0.0000 |
| 5 | Platinum-based Drug [EPC] | 2 | 0.0000 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 2 | 0.0000 |
| 7 | Expectorant [EPC] | 1 | 0.0000 |
| 8 | Osmotic Laxative [EPC] | 1 | 0.0000 |
| 9 | GLP-1 Receptor Agonist [EPC] | 1 | 0.0000 |